Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...

Acadia Pharmaceuticals isn’t taking its recent rejection from the European Medicines Agency lying down, vowing to seek a re-examination of the decision from the regulator's Committee for Medicinal | ...

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) will request a re-examination of a negative opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on its ...

The swim club, which was based out of Acadia University’s pool, learned 13 months ago the educational institute was closing ...

A European regulatory body adopted a negative opinion regarding Acadia Pharmaceuticals' application for trofinetide, its treatment for Rett syndrome, a rare neurodevelopmental disorder seen in ...

Investors are warming to the ASX-listed cryogenic plays as they surf the strong need for temperature-controlled storage for ...

Baystreet.ca News Commentary – A growing body of clinical evidence is pushing neuroscience-based therapies from early ...

A five-day itinerary through southern Louisiana threads across Cajun Country — a world of shadowy swamps, gothic beauty and ...

Neuren Pharmaceuticals shares are looking cheap with a solid income stream from its Daybue drug, Macquarie says.

This stock is having a tough session. Let's find out what's going on. The post Why is this ASX 200 stock sinking 6% today?

When Will Pattiz learned that Yosemite was eliminating its timed-entry system, he experienced a flashback to 2023. That year, the California national park had halted the reservation system it had ...

More than 520 guests from across Greater Vancouver's philanthropic community gathered for the 19th annual Scotiabank Feast of Fortune Gala hosted by St. Paul's Foundation. The event raised over $2.5 ...